OUR COMPANY
Our Mission
To address a critical gap in the fight against Alzheimer’s Disease by delivering effective risk screening for better detection, earlier treatment, and effective prevention.
Our Vision
A world where everyone over 50 is screened for Alzheimer’s risk, helping turn the tide against the disease through better foresight.
Sensitivity detecting who will be diagnosed with Alzheimer’s.
Screening for disease risk up to 10 years out.
More sensitive than existing screening methods.
Biomarkers used, universally present in common medical records.
Real world patient medical records trained with AI.
An experienced founder and executive with 25 years in medical technologies, including imaging, diagnostics, surgery, mental health, and venture capital. Proven track record of creating value through strategic leadership.
Hayim Raclaw
Director, Chief Executive Officer & Co-founder
Over 15 years in startups, finance, and strategy across Israel, Europe, the US, Canada, and LATAM, including M&A leadership at IMC (NASDAQ: IMCC, CSE: IMCC) with $180M+ in transactions. Reserve pilot in the Israeli Air Force.
Roy Kait
Director, Chief Revenue Officer & Co-founder
Senior Neurologist at Clalit Health Services in Israel and Head of the Cognitive Neurology Service at Beilinson Hospital, Rabin Medical Center, part of the Clalit network. Holds multiple registered patents across various research projects in cognitive neurology.
Dr. Amir Glik, MD
Director, Chief Medical Officer & Co-founder
Over 15 years as a Group CFO in private and public companies (TASE: GIX), including foreign subsidiaries or mother companies in the US, UK and South America.
A demonstrated history of working in Various industries such as Marketing/Internet, SaaS, and Medical Devices, that includes going thru IPO’s and M&A.
Israel Messer
CFO
A decade of experience in venture creation, business development, operations, and venture investments across digital health, proptech, agritech, foodtech, and deep-tech sectors, with a proven track record in strategic growth, marketing, partnerships, and commercialization within the Israeli innovation ecosystem.
Ofri Kait
VP Business Development
& Operations & Co-Founder
Brings over two decades of R&D leadership, building AI-driven healthcare products and data platforms that turn advanced technology into scalable, high-impact solutions.
Boaz Citrin
VP R&D
Seasoned biotech executive and Harvard-trained bioethicist, 15+ years across science, AI and business, successfully leading multiple health and longevity ventures to IPO, advancing ALZAI’s predictive neuroscience mission.
Erin Sharoni
VP Commercial
A highly accomplished Executive Assistant, with15 years experience in team leadership and operations management, 10 years as an EA specializing in the fields of accounting, finance, and health tech.
Jenny Greer
Executive Assistant
Founder of the Data Science and AI Research Center and faculty member in the Department of Industrial Engineering and Management at Ariel University. A recognized expert in machine learning, with extensive research and applied AI experience.
Prof. Chen Hajaj
Head of Data Science
& Co Founder
Faculty member and Head of the Data Science M.Sc. Program at Ariel University, specializing in machine learning and artificial intelligence with extensive academic and applied experience.
Anat Goldstein
AI Expert
& Co-Founder
A medical data scientist specializing in AI-driven early-detection algorithms, combining expertise in clinical machine-learning pipelines with advanced medical analytics. Brings a neuroscience background and experience leading computational product development in early-stage startups.
Gal Aviram
Senior Data
Scientist
Marianna Abajyan holds a B.Sc. in Digital Medical Technologies from the Holon Institute of Technology, graduating cum laude. She works as a data analyst specializing in medical data and healthcare insights and volunteers at the Pediatric Emergency Medicine Unit of the Dana-Dwek Children’s Hospital at the Tel Aviv Medical Center.
Marianna Abajyan
Data Analyst
An experienced founder and executive with 25 years in medical technologies, including imaging, diagnostics, surgery, mental health, and venture capital. Proven track record of creating value through strategic leadership.
Hayim Raclaw
Director, Chief Executive Officer & Co-founder
Over 15 years in startups, finance, and strategy across Israel, Europe, the US, Canada, and LATAM, including M&A leadership at IMC (NASDAQ: IMCC, CSE: IMCC) with $180M+ in transactions. Reserve pilot in the Israeli Air Force.
Roy Kait
Director, Chief Revenue Officer & Co-founder
Senior Neurologist at Clalit Health Services in Israel and Head of the Cognitive Neurology Service at Beilinson Hospital, Rabin Medical Center, part of the Clalit network. Holds multiple registered patents across various research projects in cognitive neurology.
Dr. Amir Glik, MD
Director, Chief Medical Officer & Co-founder
An accounting and finance professional with over 7 years as a capital markets executive, assisting companies across various sectors with go-public transactions, leadership, governance and restructuring.
Faizaan Lalani
Director
Seasoned financial and entrepreneurial leader with over 17 years of experience in business development, strategy, and corporate growth. Co-founder of 14 companies with five successful exits exceeding $290M in total value.
Mark Goldhar
Director
Med-Tech CEO who led a medical imaging company to NASDAQ & TSX IPO before its $500M acquisition by IBM. Co-founded Fio Corporation, pioneering Fionet for diagnostics. MD from UPenn, neurosurgery residency and NIH post-doc at UofT.
Dr. Michael Greenberg, MD
Neurosurgeon, Entrepreneur, PubCo CEO, Experienced company developer
Chief of Biomedical Genetics at Boston University. Led NIH-funded research identifying genetic risk factors for Alzheimer’s. PI of the Framingham Heart Study – Brain Aging Program. Authored 500+ publications. Ph.D. from Indiana University, post-doc at Yale.
Prof. Lindsay A. Farrer, Ph.D.
Leading NIH-funded programs, identified causal factors for AD
Founder & CEO of Datos, a leading patient engagement platform used by Kaiser Permanente and Mayo Clinic. Former GM at NCR and VP at Retalix, with 18 years as a technology executive. BSc and Master’s in Engineering from Technion.
Uri Bettesh
Founder & CEO of Datos, Patient Engagement Platform for Healthcare
